The advertisement promotes Xtandi (enzalutamide) for the treatment of nonmetastatic castration-sensitive prostate cancer, highlighting updated clinical data and important safety information regarding seizure risks.
Creative Information
| CID: | b9c09ceb-6e26-4954-8a40-b291d6242ac0 |
| CRID: | 82_7182-947403 |
| Domain: | xtandihcp.com |
| Seat: | PP |
| Size: | 300x250 |
| Bid: | $78.38 |
| Timestamp: | 10/31/2025, 6:05:04 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 10/31/2025, 7:06:27 PM | 5.21s | |
| adomain_analysis | success | 10/31/2025, 8:51:07 PM | 3.44s | |
| adomain_capture | success | 10/31/2025, 8:51:03 PM | 0.10s | |
| ad_render | success | 10/31/2025, 7:06:21 PM | 24.50s | |
| brand_mapping | success | 10/31/2025, 6:05:04 PM | 0.21s | |
Analysis Results
Ad Format: banner
Brands: XTANDI
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 300x250 | ||||||||||||||||||||||
| Data Transferred: | 1355.24 KB | ||||||||||||||||||||||
| Render Time: | 9.06 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1366.06 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives


